AptarGroup's Aptar Pharma Reveals CE Marking For LuerVax

Aptar Pharma, a division of AptarGroup, Inc. (NYSE: ATR), has received CE marking for its LuerVax® intranasal delivery device and Spray Divider, signifying compliance with the EU Medical Device Regulation. This certification enhances Aptar Pharma's capabilities in supporting the development of innovative intranasal vaccine products.